| Literature DB >> 27599999 |
Paolo Indolfi1,2, Serena Picazio3, Silverio Perrotta4, Francesca Rossi4, Andrea Pession5, Martina Di Martino4, Elvira Pota4, Daniela Di Pinto4, Cristiana Indolfi4, Roberto Rondelli5, Francesco Vetrano6, Fiorina Casale4.
Abstract
BACKGROUND: Childhood cancer is relatively uncommon and the European age-standardized rate was 164 new case per million per year among children 0 to 14 years of age (95 % CI 158-170). Aims of our study are to evaluate the cases of these malignant diseases observed between 0 and 15 years of age in the Campania region between 1990 and 2014, the ration between observed and expected cases by disease and province of residence. Also we studied the percentage of extra-regional migration over the time by disease and province of residence.Entities:
Keywords: Cancer; Children; Epidemiology
Mesh:
Year: 2016 PMID: 27599999 PMCID: PMC5013613 DOI: 10.1186/s13052-016-0287-y
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Characteristics and numbers of children (0–15 years old) diagnosed with cancer in Campania Region between 1990 and 2014, registered in the AIEOP Mod. 1.01
| Diagnostic period | No (%) of patients |
|---|---|
| 1990–1994 | 611 (16.7) |
| 1995–1999 | 673 (18.4) |
| 2000–2004 | 726 (19.8) |
| 2005–2009 | 806 (22.0) |
| 2010–2014 | 839 (22.9) |
| Sex | |
| Male | 2036 (55.7) |
| Female | 1619 (44.2) |
| Type of Disease | |
| Acute lymphoblastic/hybrid Leukemia | 1036 (28.3) |
| Acute non lymphoblastic Leukemia | 220 (6.0) |
| Chronic Myeloid Leukemia | 24 (0.6) |
| Non Hodgkin Lymphoma | 281 (7.6) |
| Hodgkin Lymphoma | 189 (5.1) |
| CNS Tumours | 500 (13.6) |
| No CNS Tumours | 1405 (38.4) |
| Province of residence | |
| Napoli | 2059 (56.3) |
| Salerno | 625 (17.0) |
| Caserta | 589 (16.1) |
| Avellino | 229 (6.2) |
| Benevento | 153 (4.1) |
Observed malignant cancer cases by disease and period of observation (%)
| Disease | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 |
|---|---|---|---|---|---|
| ALL | 210 (20.5) | 193 (18.8) | 205 (20.0) | 199 (19.4) | 217 (21.1) |
| LA hybrid/undiff. | 6 (50.0) | 4 (33.3) | 1 (8.3) | 1 (8.3) | 0 |
| ANLL | 39 (17.7) | 42 (19.0) | 40 (18.1) | 50 (22.7) | 49 (22.2) |
| MCL | 5 (20.8) | 3 (12.5) | 3 (12.5) | 4 (16.6) | 9 (37.5) |
| NHL | 52 (18.5) | 63 (22.4) | 59 (20.9) | 61 (21.7) | 46 (16.3) |
| HL | 16 (8.4) | 35 (18.5) | 35 (18.5) | 41 (21.6) | 62 (32.8) |
| Neuroblastoma | 75 (21.9) | 58 (16.9) | 67 (19.5) | 72 (21) | 70 (20.4) |
| CNS Tumour | 31 (6.2) | 78 (15.6) | 118 (23.6) | 122 (24.4) | 151 (30.5) |
| Kidney Tumour | 44 (21.7) | 45 (22.2) | 29 (14.3) | 39 (19.3) | 45 (22.2) |
| Soft tissue sarcoma | 31 (14.6) | 44 (20.7) | 45 (21.2) | 56 (26.4) | 36 (16.9) |
| Histiocytosis | 25 (14.8) | 27 (16.0) | 33 (19.6) | 47 (27.9) | 36 (21.4) |
| GCT | 15 (14.0) | 18 (16.8) | 12 (11.2) | 29 (27.1) | 33 (30.8) |
| S. Ewing/PNET | 14 (12.8) | 20 (18.3) | 22 (20.1) | 22 (20.1) | 31 (28.4) |
| Retinoblastoma | 16 (20.7) | 9 (11.6) | 22 (28.5) | 20 (25.9) | 10 (12.9) |
| Bone Tumour | 16 (25.3) | 12 (19.0) | 8 (12.6) | 14 (22.2) | 13 (20.6) |
| Liver Tumour | 6 (13.3) | 12 (26.6) | 9 (20.0) | 8 (17.7) | 10 (22.2) |
| Nasofaryngeal carcinoma | 3 (33.3) | 1 (11.1) | 2 (22.2) | 2 (22.2) | 1 (11.1) |
| Adrenocortical carcinoma | 3 (27.2) | 2 (18.1) | 3 (27.2) | 0 | 3 (27.2) |
| Other Tumours | 4 (6.6) | 7 (11.6) | 13 (21.6) | 19 (31.6) | 17 (28.3) |
| Total | 611 (16.7) | 673 (18.4) | 726 (19.8) | 806 (22) | 839 (22.9) |
ALL acute lymphoblastic leukemia, ANLL acute non lymphoblastic leukemia, MCL myeloid chronic leukemia, NHL non hodgkin lymphoma, HL hodgkin lymphoma, CNS central nervous system, GCT germ cell tumour, PNET peripheral neuroectodermal tumor
Ratio between observed and expected cases by type of cancer and period of observation (%)
| Disease | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 | ||
|---|---|---|---|---|---|---|---|
| E | O | O/E | O/E | O/E | O/E | O/E | |
| Leukemias | 260 | 260 | 1.0 | 0.93 | 0.95 | 0.97 | 1.0 |
| Limphomas | 115 | 68 | 0.59 | 0.85 | 0.81 | 0.88 | 0.93 |
| CNS tumours | 205 | 31 | 0.15 | 0.38 | 0.57 | 0.59 | 0.73* |
| Solid tumours (no CNS) | 305 | 252 | 0.82 | 0.83 | 0.86 | 1.0 | 1.0 |
CNS central nervous system, E expected cases/five years, O observed cases/five years
*p < 0.05 for trend across diagnostic periods
Ration between observed and expected cases by province of residence at diagnosis and period of observation (%)
| Province of | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 | ||
|---|---|---|---|---|---|---|---|
| E/5 years | O | O/E | O/E | O/E | O/E | O/E | |
| Napoli | 465 | 344 | 0.73 | 0.82 | 0.90 | 0.98 | 0.96* |
| Caserta | 130 | 101 | 0.77 | 0.71 | 0.83 | 0.99 | 1.2* |
| Salerno | 140 | 97 | 0.69 | 0.84 | 0.85 | 0.94 | 1.1 |
| Avellino | 50 | 40 | 0.80 | 1.0 | 0.80 | 1.0 | 0.90 |
| Benevento | 35 | 29 | 0.82 | 0.74 | 1.0 | 0.94 | 0.77 |
E expected cases/five years, O observed cases/five years
*p < 0.05 for trend across diagnostic periods
Extra-regional migration of the 3655 patients studied by disease and province of residence
| Disease | No patients/total (%) |
|---|---|
| Acute lymphoblastic/hybrid Leukemia | 143/1036 (13.8) |
| Acute non lymphoblastic Leukemia | 37/220 (16.8) |
| Chronic Myeloid Leukemia | 3/24 (12.5) |
| Non Hodgkin Lymphoma | 73/281 (25.9) |
| Hodgkin Lymphoma | 47/189 (24.8) |
| Neuroblastoma | 93/342 (28.9) |
| CNS Tumours | 251/500 (50.2) |
| Kidney Tumours | 44/202 (21.7) |
| Soft Tissue Sarcoma | 70/212 (33.0) |
| Histiocytosis | 40/168 (23.8) |
| Germinal Cell Tumours | 24/107 (22.4) |
| S. Ewing/PNET | 57/109 (52.2) |
| Retinoblastoma | 50/77 (64.9) |
| Bone Tumours | 42/63 (66.6) |
| Liver Tumours | 22/45 (48.8) |
| Other Tumours | 27/60 (45.0) |
| Total | 1029/3655 (28.1) |
| Province of residence | |
| Napoli | 392/2059 (19.0) |
| Salerno | 266/625 (42.5) |
| Caserta | 175/589 (29.7) |
| Avellino | 104/229 (45.4) |
| Benevento | 68/153 (44.4) |
CNS central nervous system, PNET peripheral neuroectodermal tumor
Extra-regional migration by period of observation and type of disease (%)
| Disease | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 |
|---|---|---|---|---|---|
| ALL | 40 (18.5) | 29 (15) | 29 (14.7) | 23 (11.1) | 22 (10.1) |
| ANLL | 15 (38.4) | 7 (16.6) | 3 (7.5) | 7 (14) | 6 (12.2) |
| MCL | 1 (20.0) | 1 (33.3) | 1 (33.3) | 0 | 0 |
| NHL | 19 (36.5) | 22 (34.9) | 18 (30.5) | 12 (19.6) | 2 (4.3) |
| HL | 5 (31.2) | 8 (22.8) | 14 (40.0) | 9 (21.9) | 11 (17.7) |
| Neuroblastoma | 32 (42.6) | 22 (37.9) | 17 (25.3) | 19 (26.3) | 9 (12.8) |
| CNS Tumour | 25 (80.6) | 40 (51.2) | 67 (56.7) | 66 (54) | 53 (35.0) |
| Kidney Tumour | 14 (31.8) | 10 (22.2) | 7 (24.1) | 7 (17.9) | 6 (13.3) |
| Soft tissue sarcoma | 12 (38.7) | 10 (22.7) | 20 (44.4) | 20 (35.7) | 8 (22.2) |
| Histiocytosis | 4 (16.0) | 7 (25.9) | 10 (30.3) | 10 (21.2) | 9 (25.0) |
| GCT | 4 (26.6) | 3 (16.6) | 4 (33.3) | 7 (24.1) | 6 (18.1) |
| S. Ewing/PNET | 9 (64.2) | 14 (70.0) | 8 (36.3) | 9 (40.9) | 17 (54.8) |
| Retinoblastoma | 2 (12.5) | 3 (33.3) | 17 (77.2) | 18 (90) | 10 (100) |
| Bone Tumour | 15 (93.7) | 11 (91.6) | 6 (75.0) | 7 (50) | 3 (23.0) |
| Liver Tumour | 4 (66.6) | 7 (58.3) | 4 (44.4) | 4 (50) | 3 (30.0) |
| Other Tumours | 5 (50.0) | 6 (60.0) | 4 (22,2) | 5 (23.8) | 7 (33.3) |
| Total | 206/611 (33.7) | 200/673 (29.7) | 229/726 (31.5) | 223/806 (27.6) | 171/839 (20.3) |
ALL acute lymphoblastic leukemia, ANLL acute non lymphoblastic leukemia, MCL myeloid chronic leukemia, NHL non hodgkin lymphoma, HL hodgkin lymphoma, CNS central nervous system, GCT germ cell tumour, PNET peripheral neuroectodermal tumor
Extra-regional migration by province of residence at diagnosis and period of observation of the 1029 patients examined (%)
| Province of residence | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 |
|---|---|---|---|---|---|
| Napoli | 85 (24.7) | 72 (18.7) | 92 (21.9) | 82 (17.8) | 61 (13.5) |
| Caserta | 32 (31.6) | 31 (33.3) | 40 (37.0) | 39 (30.2) | 33 (20.8) |
| Salerno | 44 (45.3) | 53 (44.9) | 56 (46.6) | 55 (41.6) | 58 (36.7) |
| Avellino | 21 (52.5) | 23 (45) | 19 (47.5) | 29 (54.7) | 12 (26.6) |
| Benevento | 17 (58.6) | 12 (46.1) | 18 (47.3) | 14 (42.4) | 7 (25.9) |